Venture Capital Accelerating and Shifting to AI and Other Breakthrough Technologies

Global Venture capital for 2018 and 2019 has been about $200-250 billion. US Venture capital reached $130 billion. This surpassed the level in 2000 when it was $100 billion.

There is $9-10 billion per year funding Artificial Intelligence and $5.8 billion invested in space. These amounts have been increasing. There was $850 million invested into antiaging in 2018 and about $1-2 billion invested in antiaging in 2019. The exact amounts invested in rejuvenating antiaging depends upon how antiaging is defined.

The decade of 2000-2009 had about half of the average venture capital each year versus 2010-2019.

The percentage of venture funding for breakthrough technologies is increasing.

Overall global venture capital could increase to $400-500 billion each year for 2020-2029 and the breakthrough percentages should increase.

There could even be a faster rush if there are breakout companies in each of the areas. Massive SpaceX success or other space startups could create a boom like there was in internet stocks. This could also happen in AI and antiaging.

7 thoughts on “Venture Capital Accelerating and Shifting to AI and Other Breakthrough Technologies”

  1. Stopping and preventing senescence is easy and inexpensive. The challenge is to find a profitable method that can be patented. The next trick is to help people understand and adopt the therapy.

    Reply
  2. Spin up a hab and cover it with water. There. Both solved.

    (Granted, it’s a bit more complicated, but that’s the general concept.)

    Reply
  3. It’s possible that space is a big mirage, an illusory promised land which may be disproven once radiation and low gravity are found to take a severe toll.

    Reply
  4. Where does the 1-2 billion in venture capital invested in anti aging come from (unless you count cancer treatments)? Outside of Unity the Senolytics segment has probably pulled in less than 100 million to date.

    I’d really like to see Brian and his team start to differentiate between treatments that modify a diseased metabolism brought on by the underlying damage that is aging, and treatments that seek to remove the damage. The second type of treatment should have large effects compared to the first. And slowing/mitigating aging a bit is not much good to people who are already old.

    at least damage removal areas other than senolytics are now out of the lab and in development at companies like Revel Pharma and Undersog therapeutics and Repair Bio.

    Reply
  5. But even back in the 1500s, North America already had people who claimed the right to dictate what somebody can/must do with their territory.

    They just didn’t have the technological and organisational chops to make it stick when dealing with settlers from the more technically advanced parts of the world.

    Which probably applies to the Sahara desert too.

    Reply
  6. The obvious reason is that you’d have to deal with the people who already claim jurisdiction over the Sahara.

    People already on Earth, who claim the right to dictate what somebody can/must do if they’re within certain territories, are one of the biggest motivations for colonizing space, just as they were a major motive for colonizing North America.

    Reply
  7. A cool place to visit sure. But migrate there by the thousands, never mind by the millions? Why not just buy a big chunk of the Sahara and build sealed domes there?

    Reply

Leave a Comment